Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2747997276
